Trial Profile
Phase I, Randomised, Double-masked, Placebo-controlled, Combined Single and Multiple Ascending Dose Study to Evaluate Safety, Tolerability and Pharmacokinetics of rhNGF Eye Drops in Healthy Male and Female Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Cenegermin (Primary)
- Indications Dry eyes; Keratitis
- Focus Therapeutic Use
- Sponsors Dompe Farmaceutici; Dompe Spa
- 14 Apr 2014 New trial record